A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer
Open Access
- 1 August 2002
- journal article
- letter
- Published by BMJ in Journal of Medical Genetics
- Vol. 39 (8) , 608-610
- https://doi.org/10.1136/jmg.39.8.608
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Genetic interactions between tumor suppressors Brca1 and p53 in apoptosis, cell cycle and tumorigenesisNature Genetics, 2001
- DNA double-strand breaks: signaling, repair and the cancer connectionNature Genetics, 2001
- Gene-Expression Profiles in Hereditary Breast CancerNew England Journal of Medicine, 2001
- In search of the tumour-suppressor functions of BRCA1 and BRCA2Nature, 2000
- Low expression of bcl-2 in Brca1-associated breast cancersBritish Journal of Cancer, 2000
- BRCA1 Facilitates Stress-induced Apoptosis in Breast and Ovarian Cancer Cell LinesJournal of Biological Chemistry, 2000
- The Breast Cancer Susceptibility Gene BRCA1 Is Required for Subnuclear Assembly of Rad51 and Survival following Treatment with the DNA Cross-linking Agent CisplatinJournal of Biological Chemistry, 2000
- Multifactorial Analysis of Differences Between Sporadic Breast Cancers and Cancers Involving BRCA1 and BRCA2 MutationsJNCI Journal of the National Cancer Institute, 1998
- Double-Strand Break Repair Deficiency and Radiation Sensitivity in BRCA2 Mutant Cancer CellsJNCI Journal of the National Cancer Institute, 1998
- Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2Nature, 1997